ICCCIMMUCELL CORP /DE/
- GlobeNewswire
ImmuCell Announces a 46% Increase in Product Sales in Quarter Three of 2026, Based on Preliminary, Unaudited Sales Results
PORTLAND, Maine, Oct. 12, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (NASDAQ:ICCC) ("ImmuCell" or the "Company"), an animal health biologics company that develops, manufactures and markets products ...
- GlobeNewswire
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2026
PORTLAND, Maine, Aug. 13, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (NASDAQ:ICCC) ("ImmuCell" or the "Company"), an animal health biologics company that develops, manufactures and markets products ...
- GlobeNewswire
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2026
PORTLAND, Maine, Aug. 06, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (NASDAQ:ICCC) ("ImmuCell" or the "Company"), an animal health biologics company that develops, manufactures and markets products ...
- GlobeNewswire
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026
PORTLAND, Maine, May 14, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (NASDAQ:ICCC) ("ImmuCell" or the "Company"), an animal health biologics company that develops and markets products to improve calf health and ...
- GlobeNewswire
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2026
PORTLAND, Maine, May 07, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (NASDAQ:ICCC) ("ImmuCell" or the "Company"), an animal health biologics company that develops and markets products to improve calf health and ...
- GlobeNewswire
ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors
PORTLAND, Maine, April 13, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (NASDAQ:ICCC) ("ImmuCell" or the "Company"), an animal health biologics company that develops and markets products to improve calf health and ...
- GlobeNewswire
ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales Results
PORTLAND, Maine, April 08, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), an animal health biologics company that develops, manufactures and markets products to improve calf ...
- GlobeNewswire
ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025
PORTLAND, Maine, March 04, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), an animal health company that develops, manufactures and markets products that improve cattle ...
- GlobeNewswire
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025
PORTLAND, Maine, Feb. 18, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (NASDAQ:ICCC) ("ImmuCell" or the "Company"), an animal health company that develops, manufactures and markets products that improve cattle health ...
- GlobeNewswire
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025
PORTLAND, Maine, Jan. 08, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (NASDAQ:ICCC) ("ImmuCell" or the "Company"), an animal health company that develops, manufactures and markets products that improve cattle health ...
- GlobeNewswire
ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus
PORTLAND, Maine, Jan. 07, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (NASDAQ:ICCC) ("ImmuCell" or the "Company"), an animal health company that develops, manufactures and markets products that improve cattle health ...
- GlobeNewswire
ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain®
PORTLAND, Maine, Dec. 24, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (NASDAQ:ICCC) ("ImmuCell"), an animal health company that develops, manufactures and markets products that improve cattle health and productivity ...
- GlobeNewswire
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2025
PORTLAND, Maine, Nov. 13, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and ...
- GlobeNewswire
ImmuCell Announces Onboarding of New CEO and Related Management Changes
PORTLAND, Maine, Nov. 04, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and ...
- SEC
8-K Form - Current report, items 2.02 and 9.01 - IMMUCELL CORP /DE/ (0000811641) (Filer)
Current report, items 2.02 and 9.01 ...
- GlobeNewswire
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 of 2025
PORTLAND, Maine, Oct. 07, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and ...
- SEC
8-K Form - Current report, items 1.01, 5.02, and 9.01 - IMMUCELL CORP /DE/ (0000811641) (Filer)
Current report, items 1.01, 5.02, and 9.01 ...
- GlobeNewswire
ImmuCell Announces Selection of its Next President and CEO
PORTLAND, Maine, Sept. 29, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and ...
- SEC
8-K Form - Current report, items 1.01, 2.03, and 9.01 - IMMUCELL CORP /DE/ (0000811641) (Filer)
Current report, items 1.01, 2.03, and 9.01 ...
- Earnings Call Transcripts
ImmuCell Corporation (ICCC) Q2 2025 Earnings Call Transcript
ImmuCell Corporation (ICCC) Q2 2025 Earnings Call Transcript ...
- GlobeNewswire
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2025
PORTLAND, Maine, Aug. 14, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and ...
- GlobeNewswire
ImmuCell Announces Bank Debt Refinancing
PORTLAND, Maine, Aug. 12, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and ...
- GlobeNewswire
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2025
PORTLAND, Maine, Aug. 07, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and ...
- SEC
8-K Form - Current report, items 8.01 and 9.01 - IMMUCELL CORP /DE/ (0000811641) (Filer)
Current report, items 8.01 and 9.01 ...
- GlobeNewswire
ImmuCell Embarks on CEO Succession Planning Process
PORTLAND, Maine, June 25, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and ...